PharmaCyte Biotech (PMCB) Preferred Shares Issued (2023)
PharmaCyte Biotech (PMCB) has disclosed Preferred Shares Issued for 1 consecutive years, with -$1.3 million as the latest value for Q4 2023.
- Quarterly Preferred Shares Issued changed N/A to -$1.3 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$1.3 million through Jul 2024, down 103.86% year-over-year, with the annual reading at $33.7 million for FY2024, N/A changed from the prior year.
- Preferred Shares Issued for Q4 2023 was -$1.3 million at PharmaCyte Biotech, down from $35.0 million in the prior quarter.
- The five-year high for Preferred Shares Issued was $35.0 million in Q3 2023, with the low at -$1.3 million in Q4 2023.